Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9532]

Radioterapia Intraoperatoria con Electrones (ELIOT) en Cáncer de Mama:...

Dr Mattia Intra - Instituto Europeo de Oncología, Milán, Italia

Radioterapia Intraoperatoria con Electrones (ELIOT) en Cáncer de Mama: Experiencia del Instituto Europeo de Oncología ( Dr Mattia Intra - Instituto Europeo de Oncología, Milán, Italia )

Epidemiología y Factores de Riesgo del Cáncer de Mama en México

Dr Jaime de la Garza - Instituto Nacional de Cancerologia, Mexico

Epidemiología y Factores de Riesgo del Cáncer de Mama en México ( Dr Jaime de la Garza - Instituto Nacional de Cancerologia, Mexico )

Breast Cancer in Latin America

Dr Eduardo Cazap - SLACOM, Buenos Aires

Breast Cancer in Latin America ( Dr Eduardo Cazap - SLACOM, Buenos Aires )

Radioterapia personalizada: cáncer de mama 2015. El paradigma de la adaptación...

Dr Felipe A. Calvo - Universidad Complutense , Madrid, Spain

Radioterapia personalizada: cáncer de mama 2015. El paradigma de la adaptación bio-tecnológica ( Dr Felipe A. Calvo - Universidad Complutense , Madrid, Spain )

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA

Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )

TAT 2016: Targeted anticancer therapies

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA

TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )

Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands

$Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )$

EHA 2015 highlights

Peter Goodwin - ecancer reporter

EHA 2015 highlights ( Peter Goodwin - ecancer reporter )

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )

Are CML patients being treated to the correct standard?

Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany

Are CML patients being treated to the correct standard? ( Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany )

Exciting new developments in proton therapy treatments

Dr Hernán Cortés-Funes - HC Marbella, Marbella, Spain

Exciting new developments in proton therapy treatments ( Dr Hernán Cortés-Funes - HC Marbella, Marbella, Spain )

More from ecancer